These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1096844)

  • 1. Adsorption of pneumocins and aerocins on bacterial cells.
    Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):215-23. PubMed ID: 1096844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concept of bacteriocins.
    Reeves P
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):78-89. PubMed ID: 388936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Escherichia coli population following treatment with bacteriocins from lactic acid bacteria and chelators.
    Belfiore C; Castellano P; Vignolo G
    Food Microbiol; 2007 May; 24(3):223-9. PubMed ID: 17188201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
    del Castillo FJ; del Castillo I; Moreno F
    J Bacteriol; 2001 Mar; 183(6):2137-40. PubMed ID: 11222617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antimicrobial spectrum of the action of bacteriocins and bacteriophages from Klebsiella strains].
    Sharga BM; Turianitsa AI
    Mikrobiol Z; 1993; 55(5):59-68. PubMed ID: 8162198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the bacteriocin PsVP-10 produced by Pseudomonas sp. on sensitive bacterial strains.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    Rev Latinoam Microbiol; 2002; 44(1):19-23. PubMed ID: 17061511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic sensitivity and the chemical structures of the bacterial wall].
    Shoshiev LN; Orlova GM; Makarovskaia LN
    Antibiotiki; 1980 Jun; 25(6):468-74. PubMed ID: 6994633
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and characteristics of aerocin 2 produced by Enterobacter aerogenes.
    Maresz-Babczyszy J; Starzyk E
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):729-41. PubMed ID: 4589300
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147.
    Guinane CM; Cotter PD; Hill C; Ross RP
    FEMS Microbiol Lett; 2006 Jul; 260(1):77-83. PubMed ID: 16790021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial agents responsible for urinary tract infections. III. A clinico-statistical contribution].
    Roscioni C; Pennelli GM; Monaco G; Roscioni MC
    Clin Ter; 1988 Aug; 126(3):207-15. PubMed ID: 2974387
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
    Poudyal A; Howden BP; Bell JM; Gao W; Owen RJ; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2008 Dec; 62(6):1311-8. PubMed ID: 18922815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory experiments with uropathogenic bacteria and chlorhexidine.
    Korner B; Kühle P; Christensen SC
    Acta Chir Scand Suppl; 1973; 433():110-2. PubMed ID: 4196567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.